Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Compodium | COMPDM | 22. nov 2024 | 5.70 | 0.00 |
Concejo B | CNCJOB | 22. nov 2024 | 41.10 | -1.20 |
Condo Nordic Holding AB | CONDO | 22. nov 2024 | 1.50 | -4.46 |
Consensus B | CAMB | 22. nov 2024 | 11.85 | -4.05 |
Coor Service Management Holding | COOR | 22. nov 2024 | 32.96 | +0.30 |
Corem Property Group A | COREA | 22. nov 2024 | 6.76 | +0.90 |
Corem Property Group B | COREB | 22. nov 2024 | 6.76 | +2.73 |
Corem Property Group D | CORED | 22. nov 2024 | 246.50 | -0.40 |
Corem Property Group Pref | COREPREF | 22. nov 2024 | 262.00 | +2.14 |
Corline Biomedical | CLBIO | 22. nov 2024 | 6.42 | -2.73 |
Cortus Energy | CE | 22. nov 2024 | 0.16 | -1.83 |
Creades A | CREDA | 22. nov 2024 | 70.30 | +1.88 |
Creturner Group | CRET | 22. nov 2024 | 0.16 | 0.00 |
Crown Energy | CRWN | 22. nov 2024 | 0.58 | -17.14 |
Crunchfish | CFISH | 22. nov 2024 | 1.29 | -7.86 |
CTEK | CTEK | 22. nov 2024 | 16.28 | -0.49 |
CTT Systems | CTT | 22. nov 2024 | 252.00 | -0.79 |
Curasight | CURAS | 22. nov 2024 | 10.90 | -5.22 |
Cyber Security 1 | CYB1 | 22. nov 2024 | 0.01 | +6.38 |
Cyclezyme AB | CYCLE | 22. nov 2024 | 7.15 | -4.67 |
Cyxone | CYXO | 22. nov 2024 | 0.03 | -5.08 |
Dala Energi | DE | 22. nov 2024 | 100.50 | +0.70 |
Dedicare B | DEDI | 22. nov 2024 | 62.00 | +1.14 |
Desenio | DSNO | 22. nov 2024 | 0.29 | +2.14 |
Deversify Health | DEV | 22. nov 2024 | 0.01 | 0.00 |
DevPort | DEVPB | 22. nov 2024 | 27.90 | -1.06 |
Devyser Diagnostics | DVYSR | 22. nov 2024 | 129.00 | -1.90 |
DexTech Medical | DEX | 22. nov 2024 | 4.08 | +5.15 |
Diadrom Holding | DIAH | 22. nov 2024 | 7.14 | +3.48 |
Diagonal Bio | DIABIO | 22. nov 2024 | 0.03 | +3.05 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.